Hangzhou Tigermed Consulting Cash Flow Conversion Efficiency
Hangzhou Tigermed Consulting cash flow conversion efficiency. Based on the latest financial reports, Hangzhou Tigermed Consulting (300347) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥475.40 Million ≈ $69.57 Million USD) by net assets (CN¥24.71 Billion ≈ $3.62 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hangzhou Tigermed Consulting (2009–2025)
Cash flow conversion efficiency of Hangzhou Tigermed Consulting from 2009 to 2025. This chart illustrates how Hangzhou Tigermed Consulting's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hangzhou Tigermed Consulting stock quote for real-time trading data and today's change.
Hangzhou Tigermed Consulting Cash Flow Conversion Ratio Explained
Hangzhou Tigermed Consulting cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hangzhou Tigermed Consulting Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hangzhou Tigermed Consulting ranked by their cash flow conversion efficiency. Also see 300347 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bruker Corporation
NASDAQ:BRKR
|
0.092x |
|
Allegro Microsystems Inc
NASDAQ:ALGM
|
0.023x |
|
PrairieSky Royalty Ltd
TO:PSK
|
0.048x |
|
Jiangsu Yoke Technology Co Ltd
SHE:002409
|
0.053x |
|
Inner Mongolia Junzheng Energy & Chemical Group Co Ltd
SHG:601216
|
0.047x |
|
Bank of Changsha Co Ltd
SHG:601577
|
1.054x |
|
ELF Beauty Inc
NYSE:ELF
|
0.096x |
|
MEIJI HLD.UN.ADR 1/4 O.N.
F:3M00
|
N/A |
Annual Cash Flow Conversion Efficiency for Hangzhou Tigermed Consulting (2009–2025)
The table below shows the annual cash flow conversion efficiency of Hangzhou Tigermed Consulting from 2009 to 2025. Review Hangzhou Tigermed Consulting free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥24.26 Billion ≈ $3.55 Billion |
CN¥1.12 Billion ≈ $163.61 Million |
0.046x | +1.12% |
| 2024-12-31 | CN¥24.06 Billion ≈ $3.52 Billion |
CN¥1.10 Billion ≈ $160.53 Million |
0.046x | -3.10% |
| 2023-12-31 | CN¥24.45 Billion ≈ $3.58 Billion |
CN¥1.15 Billion ≈ $168.35 Million |
0.047x | -21.40% |
| 2022-12-31 | CN¥22.68 Billion ≈ $3.32 Billion |
CN¥1.36 Billion ≈ $198.65 Million |
0.060x | -13.38% |
| 2021-12-31 | CN¥20.61 Billion ≈ $3.02 Billion |
CN¥1.42 Billion ≈ $208.35 Million |
0.069x | +23.56% |
| 2020-12-31 | CN¥17.86 Billion ≈ $2.61 Billion |
CN¥998.68 Million ≈ $146.14 Million |
0.056x | -41.47% |
| 2019-12-31 | CN¥5.52 Billion ≈ $807.94 Million |
CN¥527.56 Million ≈ $77.20 Million |
0.096x | -40.13% |
| 2018-12-31 | CN¥3.27 Billion ≈ $478.82 Million |
CN¥522.24 Million ≈ $76.42 Million |
0.160x | +41.95% |
| 2017-12-31 | CN¥2.80 Billion ≈ $409.92 Million |
CN¥314.97 Million ≈ $46.09 Million |
0.112x | +7.79% |
| 2016-12-31 | CN¥1.84 Billion ≈ $269.22 Million |
CN¥191.91 Million ≈ $28.08 Million |
0.104x | -40.14% |
| 2015-12-31 | CN¥1.07 Billion ≈ $155.98 Million |
CN¥185.73 Million ≈ $27.18 Million |
0.174x | +265.93% |
| 2014-12-31 | CN¥916.90 Million ≈ $134.17 Million |
CN¥43.66 Million ≈ $6.39 Million |
0.048x | -53.36% |
| 2013-12-31 | CN¥755.14 Million ≈ $110.50 Million |
CN¥77.10 Million ≈ $11.28 Million |
0.102x | +373.15% |
| 2012-12-31 | CN¥694.32 Million ≈ $101.60 Million |
CN¥14.98 Million ≈ $2.19 Million |
0.022x | -91.86% |
| 2011-12-31 | CN¥146.03 Million ≈ $21.37 Million |
CN¥38.69 Million ≈ $5.66 Million |
0.265x | -4.53% |
| 2010-12-31 | CN¥95.79 Million ≈ $14.02 Million |
CN¥26.59 Million ≈ $3.89 Million |
0.278x | -44.03% |
| 2009-12-31 | CN¥44.26 Million ≈ $6.48 Million |
CN¥21.95 Million ≈ $3.21 Million |
0.496x | -- |
About Hangzhou Tigermed Consulting
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing … Read more